These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy. Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
6. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling. Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F mBio; 2019 Feb; 10(1):. PubMed ID: 30755508 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins. Bello JO; Nieva LO; Paredes AC; Gonzalez AM; Zavaleta LR; Lizano M Viruses; 2015 Aug; 7(8):4734-55. PubMed ID: 26295406 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343 [TBL] [Abstract][Full Text] [Related]
9. Control of interferon signaling in human papillomavirus infection. Koromilas AE; Li S; Matlashewski G Cytokine Growth Factor Rev; 2001; 12(2-3):157-70. PubMed ID: 11325599 [TBL] [Abstract][Full Text] [Related]
10. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Zhang L; Wu J; Ling MT; Zhao L; Zhao KN Mol Cancer; 2015 Apr; 14():87. PubMed ID: 26022660 [TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
12. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects. Vonsky MS; Runov AL; Gordeychuk IV; Isaguliants MG Biochemistry (Mosc); 2019 Jul; 84(7):800-816. PubMed ID: 31509730 [TBL] [Abstract][Full Text] [Related]
14. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
15. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886 [TBL] [Abstract][Full Text] [Related]
16. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
17. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy. Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state. Hochmann J; Parietti F; Martínez J; Lopez AC; Carreño M; Quijano C; Boccardo E; Sichero L; Möller MN; Mirazo S; Arbiza J Mem Inst Oswaldo Cruz; 2020; 115():e190405. PubMed ID: 32187327 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer. Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725 [TBL] [Abstract][Full Text] [Related]
20. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Estêvão D; Costa NR; Gil da Costa RM; Medeiros R Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):153-162. PubMed ID: 30707946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]